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 2 
Bacteria gain antibiotic resistance genes by horizontal acquisition of なに 
mobile genetic elements (MGE) from other lineages. Newly acquired なぬ 
MGEs are often poorly adapted causing intragenomic conflicts, resolved なね 
by compensatory adaptation of the chromosome, the MGE or reciprocal なの 
coadaptation. The footprints of such intragenomic coevolution are なは 
present in bacterial genomes, suggesting an important role promoting なば 
genomic integration of horizontally acquired genes, but direct なぱ 
experimental evidence of the process is limited. Here we show adaptive なひ 
modulation of tetracycline resistance via intragenomic coevolution にど 
between Escherichia coli and the multi-drug resistant (MDR) plasmid にな 
RK2. Tetracycline treatments, including monotherapy or combination にに 
therapies with ampicillin, favoured de novo chromosomal resistance にぬ 
mutations coupled with mutations on RK2 impairing the plasmid-にね 
encoded tetracycline efflux-pump. These mutations together provided にの 
increased tetracycline resistance at reduced cost. Additionally, the には 
chromosomal resistance mutations conferred cross-resistance to にば 
chloramphenicol. Reciprocal coadaptation was not observed under にぱ 
ampicillin-only or no antibiotic selection. Intragenomic coevolution can にひ 
create genomes comprised of multiple replicons that together provide ぬど 
high-level, low-cost resistance, but the resulting co-dependence may ぬな 
limit the spread of coadapted MGEs to other lineages.   ぬに 
 ぬぬ 
  ぬね 
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Horizontal gene transfer (HGT) is a fundamental process in bacterial evolution ぬの 
that accelerates adaptation by sharing ecologically important accessory traits ぬは 
between lineages1. These accessory traits are themselves frequently located ぬば 
on semi-autonomous mobile genetic elements (MGE), such as conjugative ぬぱ 
plasmids, that encode genes for their own replication, partition and horizontal ぬひ 
transfer2,3. Conjugative multidrug resistance (MDR) plasmids, encoding ねど 
antibiotic resistance genes (ARG) against multiple classes of antibiotics, are ねな 
of particular clinical concern since they allow instantaneous acquisition of ねに 
MDR phenotypes and thus potentiate the rapid emergence of MDR bacterial ねぬ 
pathogens4,5. Newly acquired conjugative plasmids are often costly since the ねね 
plasmid is unlikely to be well adapted to the new genetic background, causing ねの 
intragenomic conflict6. The cost of plasmid carriage is likely to arise due to the ねは 
metabolic burden of maintaining, transcribing and translating plasmid genes7, ねば 
as well as via disruption of cellular homeostasis caused by gene regulatory ねぱ 
interference between chromosomal and plasmid regulators8,9, and cytotoxic ねひ 
effects of plasmid gene products6.  のど 
 のな 
An important route to resolving this intragenomic conflict is compensatory のに 
evolution to ameliorate the cost of plasmid acquisition10. Experimental のぬ 
evolution suggests that compensatory evolution can arise via mutations のね 
located on either the chromosome or the plasmid, or via intragenomic のの 
coevolution involving both plasmid and chromosome mutations8,9,11,12. のは 
Comparative genomics suggests a key role for compensatory evolution in のば 
natural bacterial populations, potentially stabilising MDR plasmids within のぱ 
lineages and thus allowing the evolutionary emergence by HGT of MDR のひ 
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pathogens13. A key outstanding question is how the mode of compensatory はど 
evolution following MDR plasmid acquisition varies with antibiotic treatment. はな 
Here we experimentally evolved Escherichia coli MG1655 carrying the MDR はに 
plasmid RK2 (encoding tetracycline and ampicillin resistance genes) under a はぬ 
range of antibiotic treatment regimes including no antibiotic, mono- and はね 
combination-therapies of tetracycline and ampicillin. Following 530 はの 
generations of selection we quantified evolved changes in antibiotic はは 
resistance and fitness, and used genome sequencing to determine the はば 
genetic bases of the observed adaptation.  はぱ 
 はひ 
Results ばど 
Thirty independent isogenic populations of E. coli MG1655 carrying the MDR ばな 
plasmid RK214, which encodes resistances to tetracycline (TET) and ampicillin ばに 
(AMP), were experimentally evolved for ~530 generations (80 days), under ばぬ 
five antibiotic treatments (six independently evolving lines per treatment): no ばね 
antibiotic (N), AMP (A), TET (T), AMP plus TET (AT), and 24 hour cycling ばの 
between AMP and TET (A/T) (see methods). Plasmids remained at high ばは 
frequency in all populations for the duration of the selection experiment. ばば 
Plasmid-free segregants were only observed at very low frequency in two of ばぱ 
the six populations from treatment N (Supplementary Fig. 1), whereas ばひ 
transposition of resistance genes from RK2 onto the host’s chromosome was ぱど 
never observed.  ぱな 
 ぱに 
To test for changes in antibiotic resistance profiles following evolution we first ぱぬ 
determined the minimum inhibitory concentration (MIC) of evolved lineages to ぱね 
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TET and AMP. The susceptibility of the evolved strains to antibiotics differed ぱの 
between treatments (Fig. 1a). We observed a four-fold increase in TET MIC in ぱは 
evolved strains from the T and AT treatments and a small increase in lineages ぱば 
that had evolved under the cycling A/T treatment compared with the ancestral ぱぱ 
MG1655 with ancestral RK2 (Anc-RK2), whereas evolved strains from ぱひ 
treatments N and A showed no change in tetracycline MIC (ANOVA, F5,30 = ひど 
6.103, p < 0.001; Post-hoc Tukey Tests, Anc-RK2:T p < 0.001, Anc-RK2:AT p ひな 
< 0.01, Anc-RK2:N p = 0.525, Anc-RK2:A p = 0.783). By contrast, we ひに 
observed no change in resistance to AMP in any treatment (ANOVA, F5,30 = ひぬ 
1.212, p = 0.327), possibly due to a lower relative selection pressure imposed ひね 
by the concentration of AMP used in the experiment compared to the ひの 
concentration of TET15. Interestingly, TET selection led to the evolution of ひは 
bacteria that were cross-resistant to chloramphenicol (CML), although the ひば 
extent of the evolved cross-resistance varied between treatments (ANOVA, ひぱ 
F5,30 = 24.25, p < 0.001); with CML MIC increasing 8-, 4-, and 2-fold in T, AT, ひひ 
A/T treatments, respectively. Consistent with CML cross-resistance being a などど 
correlated response to TET selection, evolved strains from both the N and A などな 
treatments remained equally sensitive to CML as the ancestral MG1655(RK2) などに 
(Post-hoc Tukey Tests, Anc-RK2:N p = 0.975, Anc-RK2:A p = 0.993). Thus などぬ 
whereas T and AT treatments, and to a lesser extent the cycling A/T などね 
treatment, led to the evolution increased TET resistance and cross-resistance などの 
to CML, evolved lineages from the N and A treatments showed no change in などは 
their resistance profile. などば 
 などぱ 
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To examine the genetic bases of evolved changes in resistance we next などひ 
obtained whole genome sequences for one randomly selected clone per ななど 
population. Excluding hypermutators, evolved clones had acquired between 2 ななな 
and 11 mutations, located exclusively on the chromosome in non-TET ななに 
treatments (C, N, A), and on both the chromosome and plasmid in the ななぬ 
treatments including TET (T, AT, A/T) (Supplementary Fig. 2, Supplementary ななね 
Table 1). Of all the observed mutations 13.2% were synonymous and 19% ななの 
were intergenic, the remaining non-synonymous mutations (67.8%) comprised ななは 
missense mutations (42.8%), frameshifts (10.6%), insertion sequences (5.6%) ななば 
and gene deletions (5.4%), and these were analysed further. While the ななぱ 
variance in the number of non-synonymous mutations did not differ between ななひ 
treatments (Analysis of multivariate homogeneity of group variances excluding なにど 
hypermutators F5,26 = 1.8617, p = 0.1358), the loci affected by non-なにな 
synonymous mutations did vary between treatments (Permutational ANOVA, なにに 
permutation test: F5,26 = 2.5231, p < 0.01, Bonferroni corrected). Clones that なにぬ 
had evolved under TET selection (T, AT, A/T) had significantly different sets なにね 
of non-synonymous mutations compared to evolved clones from the other なにの 
treatments (C, N, A) (permutation test: F1,30 = 6.9463, p < 0.01, Bonferroni なには 
corrected), with a larger genetic distance between TET and non-TET なにば 
treatments than within these treatment groups (Fig. 2a). Thus TET-selected なにぱ 
lineages followed an evolutionary trajectory distinct from non-TET-selected なにひ 
lineages, leading to mutations on both the chromosome and the plasmid, なぬど 
which suggest that TET selection favoured bacteria-plasmid coadaptation. なぬな 
 なぬに 
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Strikingly parallel mutations were observed between independent replicate なぬぬ 
populations both within and between TET-containing treatments (Fig. 2b). なぬね 
Highly parallel mutations are likely to represent adaptive evolution at these なぬの 
loci, and because mutations at these loci were not observed in the なぬは 
populations from the N and A treatments, these mutations were likely to be なぬば 
TET-specific adaptations. Mutations in the chromosomal genes ompF (16 out なぬぱ 
of 18 clones), and ychH (16 out of 18 clones) showed strong locus-level なぬひ 
parallelism within all three TET-containing treatments. Mutations in ompF, なねど 
encoding a major non-specific diffusion porin16, were all predicted loss-of-なねな 
function mutations, including the insertion of IS elements, frameshifts or なねに 
premature stop codons. The loss of OmpF in E. coli reduces membrane なねぬ 
permeability, including to antibiotics, and consequently is known to increase なねね 
resistance to a wide spectrum of antibiotics17 including TET and CML18,19. なねの 
Deletion of ompF (E. coli K-12 ǻompF JW091220) significantly increased なねは 
resistance to TET without the RK2 (t9.09 = 4.2836, p < 0.01), and further なねば 
increased TET resistance when carrying RK2 (Two-way ANOVA Interaction なねぱ 
F1,20 = 14.724, p < 0.01; Supplementary Fig. 4a). Parallel loss of function なねひ 
mutations (IS elements and frameshifts) in ychH were observed across all the なのど 
TET treatments. YchH is a hypothetical stress-induced inner membrane なのな 
protein21,22, but deletion of ychH (E. coli K-12 ǻychH JW119620) did not なのに 
significantly increase the resistance to TET with or without the plasmid なのぬ 
(Supplementary Fig. 4b), suggesting that this general stress response may なのね 
not be required under TET selection and is consequently selected against.  なのの 
 なのは 
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Mutations in several loci observed in the T and AT treatments were not なのば 
present in the cycling A/T treatment. These included mutations in both acrR なのぱ 
(10 out of 12 clones) and adhE (9 out of 12 clones). Mutations in adhE were なのひ 
extensively parallel at the nucleotide level, with 8 clones from independent なはど 
populations all having the same missense SNP in the ethanol dehydrogenase なはな 
domain23. The phenotypic significance of these mutations is unclear due to なはに 
the multiple roles assigned to this protein, including multiple metabolic なはぬ 
pathways24, but intriguingly the AdhE protein is known to exhibit binding なはね 
activity to the 30S ribosome25, the primary TET target. The acrR gene なはの 
encodes a repressor of AcrAB multidrug efflux pump26, the majority of なはは 
mutations in acrR are predicted loss of function mutations, with IS elements なはば 
and frameshifts observed in evolved strains. The deletion of acrR results in なはぱ 
the overexpression of acrAB leading to MDR phenotypes27,28. Deletion of acrR なはひ 
(E. coli K-12 ǻacrR JW045320) alone did not significantly increase resistance なばど 
to TET (t9.32 = -0.591, p = 0.339), but when combined with the RK2 plasmid なばな 
did allow significantly increased growth in TET (t6.4 = 3.665, p < 0.01, なばに 
Supplementary Fig. 4c). These findings are consistent with the higher TET なばぬ 
resistance of evolved clones from the T and AT treatments versus the A/T なばね 
treatment (Fig. 1a) and reflect overall weaker TET selection under the A/T なばの 
cycling compared to the T and AT treatments where TET selection was なばは 
constant. Interestingly, stronger TET selection appeared to constrain evolution なばば 
at chromosomal loci not involved in resistance. For example, we observed なばぱ 
highly parallel loss of function mutation in the flagellum operon in the A, N and なばひ 
A/T treatments, but only rarely observed mutations at these loci in T and AT なぱど 
treatments. Loss of the flagellar motility is a commonly observed adaptation of なぱな 
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E. coli to growth in liquid media29 and this may have been impeded by clonal なぱに 
interference or negative epistasis with chromosomal resistance mutations in なぱぬ 
populations under strong TET selection. Consistent with this, whereas なぱね 
evolved clones from the N and A treatments increased in fitness relative to the なぱの 
plasmid-free ancestor in antibiotic-free media, such fitness gains were not なぱは 
observed in evolved clones from the TET-containing treatments なぱば 
(Supplementary Fig. 5). なぱぱ 
 なぱひ 
To confirm that TET selection had led to the evolution of chromosomal なひど 
resistance we next cured evolved strains of their plasmids and quantified なひな 
resistance30. Evolved strains carrying putative chromosomal resistance なひに 
mutations displayed increased TET (ANOVA, F5,30 = 42.63, p < 0.001), AMP なひぬ 
(ANOVA, F5,30 = 12.55, p < 0.001) and CML (ANOVA, F5,30 = 35.88, p < なひね 
0.001) resistance (Fig. 1b). Across all tested antibiotics, evolved clones なひの 
carrying both ompF and acrR mutations had significantly increased resistance なひは 
compared to the ancestral MG1655 (Post-hoc Tukey Tests, all p < 0.05), なひば 
whereas cured evolved strains without either of these mutations (i.e. from the なひぱ 
N and A treatments) did not (Post-hoc Tukey Tests, all p > 0.05). Interestingly, なひひ 
cured evolved clones from the cycling A/T treatment that carried only にどど 
mutations in ompF but not in acrR showed marginally increased resistance to にどな 
both TET and CML, but no detectable increase in AMP resistance, relative to にどに 
MG1655. Thus TET selection favoured the de novo evolution of chromosomal にどぬ 
resistance despite pre-existing plasmid-encoded TET resistance, and these にどね 
chromosomal resistance mutations are responsible for the observed cross-にどの 
resistance to CML.  にどは 
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 にどば 
We observed parallel mutations on the plasmid exclusively in evolved clones にどぱ 
from the TET-containing treatments (T, AT, and A/T). These mutations にどひ 
occurred in tetA/tetR (18 out of 18 clones; tetA: 13, tetR: 2, both: 3, Fig. 2b) になど 
which encode the tetracycline-specific efflux pump. The expression tetA is になな 
tightly regulated by the repressor tetR in the absence of tetracycline31,32. になに 
Mutations in tetA were dispersed throughout the gene, affecting the protein’s になぬ 
transmembrane, periplasmic and cytoplasmic domains33. Three of the five になね 
mutations observed in tetR are in direct contact with or in close proximity to になの 
the tetracycline binding pocket34, while the other two mutations are located in になは 
the central scaffolding of the protein, suggesting that they are likely to になば 
interfere with activity of the tetR repressor. Evolved plasmids carrying になぱ 
mutations in tetA or tetR displayed reduced resistance to TET in the ancestral になひ 
MG1655 background compared to ancestral RK2 (Fig. 1d, ANOVA, F5,30 = ににど 
4.586, p < 0.01). Consistent with reduced efficacy of plasmid-encoded ににな 
resistance in evolved lineages with tetA/tetR mutations, when we replaced the ににに 
evolved plasmid with ancestral RK2, this led to increased TET resistance ににぬ 
(ANOVA, F5,30 = 71.86, p < 0.001, Anc-RK2:T,AT,A/T all p < 0.05).  ににね 
 ににの 
Our data suggest that evolved strains from TET-containing treatments にには 
adapted their resistance to TET by acquisition of weak chromosomal ににば 
resistance mutations in combination with mutations that reduced the efficacy ににぱ 
of the plasmid-encoded TET efflux pump. To understand the evolutionary ににひ 
benefits of this counterintuitive dual resistance strategy we first compared the にぬど 
effect of chromosomal background (evolved or ancestral) and plasmid にぬな 
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genotype (evolved or ancestral) on growth in the presence of 10 ȝg/ml TET にぬに 
(i.e., the concentration used in our selection experiment). The evolved にぬぬ 
chromosomal background carrying resistance mutations displayed a にぬね 
significantly shortened lag phase compared to the ancestral chromosomal にぬの 
background, irrespective of the plasmid genotype (Supplementary Fig. 6; にぬは 
ANOVA, F3,56 = 76.92, p < 0.001; Post-hoc Tukey Tests, Evolved にぬば 
Host:Ancestral Host all p < 0.001). This suggests that chromosomal にぬぱ 
resistances reducing membrane permeability to antibiotics allowed evolved にぬひ 
strains to start growing faster in the presence of TET.  にねど 
 にねな 
Whereas evolved bacteria grew equally well with evolved or ancestral にねに 
plasmids, ancestral bacteria displayed impaired growth with evolved にねぬ 
compared to ancestral plasmids (Supplementary Fig. 6; Max OD, W = 93, p < にねね 
0.01). This is consistent with the mutations in tetA/tetR reducing resistance にねの 
but importantly confirms that this reduction is not evident when in combination にねは 
with the chromosomal resistance mutations, which appear to compensate for にねば 
the reduced efficacy of the plasmid-encoded efflux pump.  にねぱ 
 にねひ 
We next competed evolved bacteria with either the evolved or ancestral にのど 
plasmid against the ancestral MG1665(RK2) to compare the costs of carrying にのな 
each plasmid genotype. The ancestral plasmid displayed a significantly higher にのに 
cost than the evolved plasmid in the evolved chromosomal background にのぬ 
(Supplementary Fig. 7, t25.71 = -2.287, p < 0.05). This suggests that the にのね 
mutations to tetR/tetA ameliorate the cost of plasmid carriage but at the price にのの 
of reduced efficacy of TET efflux. This is consistent with previous studies にのは 
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showing a high cost of expressing the specific tetracycline efflux pump35. にのば 
Taken together with the growth data, this suggests that although mutations to にのぱ 
tetA/tetR reduce growth under tetracycline in the ancestral chromosomal にのひ 
background, they have minimal effect on resistance in the evolved にはど 
chromosomal background due to the reduced membrane permeability and にはな 
additional efflux systems expressed in the evolved chromosomal background にはに 
carrying mutations in ompF and acrR, leading to high resistance and a にはぬ 
lowered cost of plasmid carriage. This suggests that the chromosomal にはね 
resistance mutations must have been gained prior to the mutations in the にはの 
plasmid-encoded tetracycline efflux pump. To test this, for one population にはは 
(AT2) we tracked the frequency over time of an observed IS-insertion in ompF にはば 
by PCR and then determined by sequencing when these genotypes acquired にはぱ 
mutations in the tetA/tetR genes. Consistent with the hypothesised order of にはひ 
mutations, the IS-insertion in ompF was first detected at transfer 8 and had にばど 
swept to fixation by transfer 32, whereas mutations in tetA/tetR were not にばな 




Our current model of bacterial evolution suggests that horizontal acquisition of にばは 
ARGs accelerates resistance evolution by providing bacteria with ready-made にばば 
resistance mechanisms, bypassing the requirement for rare de-novo にばぱ 
mutations1. However, recent population genomic data suggesting that にばひ 
lineages independently acquire and then subsequently coevolve with MDR にぱど 
plasmids13,36,37 imply a more dynamic evolutionary process. Consistent with にぱな 
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this, here we show here that gaining an ARG can be just the starting point in にぱに 
the evolution of resistance and, due to the costs of expressing horizontally にぱぬ 
acquired ARGs, does not preclude subsequent de novo evolution of にぱね 
chromosomal resistance. Evolved strains from TET-containing treatments にぱの 
gained chromosomal resistance mutations reducing membrane permeability にぱは 
and enhancing efflux of TET and providing cross-resistance to other にぱば 
antibiotics, shortening lag phase in the presence of TET. These mutations にぱぱ 
also reduced the need for a fully operational plasmid-encoded tetracycline にぱひ 
efflux pump, expression of which is highly costly35, allowing plasmid mutations にひど 
in the TET efflux pump and its regulator which reduced the cost of plasmid-にひな 
encoded resistance. A consequence of this intragenomic coevolution is that にひに 
the increased TET resistance of evolved strains from T, AT and A/T にひぬ 
treatments required the action of both the chromosomal- and plasmid-にひね 
encoded resistances, which together acted multiplicatively. Thus intragenomic にひの 
coevolution can lead to the evolution of bacterial genomes comprised of co-にひは 
dependent replicons, limiting the potential for onward transmission of the にひば 
plasmid due to the weaker resistance it now encodes in other lineages.  にひぱ 
 にひひ 
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Strains, culture conditions and evolution experiment ねぬひ 
E. coli MG1655 chromosomally labelled with GFP at the attB lambda ねねど 
attachment site was used in the evolution experiments. Isogenic E. coli ねねな 
MG1655-mCherry was used as a reference strain in competition and ねねに 
conjugation rate experiments. Both E. coli strains were provided by the Van ねねぬ 
Der Woude lab (University of York). The RK2 plasmid was introduced to the ねねね 
strains through conjugation from E. coli MV10 provided by the Thomas lab ねねの 
(University of Birmingham). All cultures were grown in Oxiod® Nutrient Broth ねねは 
(NB) at 37°C 5 ml in 50 ml microcosms shaken at 180 rpm. Independent ねねば 
selection lines were founded by 30 independent single colonies of E. coli ねねぱ 
MG1655-GFP harbouring RK2. These were grown overnight in non-selective ねねひ 
conditions and split into the 5 antibiotic treatments, no antibiotic selection, 100 ねのど 
ȝg/ml ampicillin, 10 ȝg/ml tetracycline, 100 ȝg/ml ampicillin plus 10 ȝg/ml ねのな 
tetracycline, and 24 hour cycling between 100 ȝg/ml ampicillin and 10 ȝg/ml ねのに 
tetracycline, with 6 replicate populations per treatment. In parallel, 6 ねのぬ 
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independent E. coli MG1655-GFP colonies were picked for control treatments ねのね 
and grown under no selection. Selection lines were established by transferring ねのの 
50 ȝl of saturated overnight culture into 5ml of selective media. These ねのは 
populations were maintained through transfer of 1% of the population into ねのば 
fresh media and antibiotics every 24 hours for 80 transfers, resulting in ~6.64 ねのぱ 
generations per day, totalling ~530 bacterial generations. For the cycling ねのひ 
treatment 3 populations were initiated with 100ȝg/ml ampicillin and 3 ねはど 
populations were initiated with 10ȝg/ml tetracycline. Culture density (OD600) ねはな 
was recorded every 24 hours. Plasmid prevalence was measure at the start ねはに 
and end of the selection experiment by screening 20 randomly picked ねはぬ 
colonies from each population using multiplex primers specific to RK2 ねはね 
replication origin (Fw: ctcatctgtcaacgccgc, Rv: aaccggctatgtcgtgct), ȕ-ねはの 
lactamase (Fw: ataactacgatacgggagggc, Rv: acatttccgtgtcgccctta), and ねはは 
tetracycline efflux pump (Fw: tgggttctctatatcgggcg,Rv: tgggcgagtgaatgcagaat). ねはば 
These primers allowed for the detection of plasmid loss and transposition of ねはぱ 
resistances onto the chromosome. One end point clone was randomly ねはひ 
selected from each population for phenotypic typing, curing, calculation of ねばど 
MICs and sequencing. Every eight transfers throughout the experiment 500 ȝl ねばな 
samples of whole populations were collected and stored in 25% glycerol at -ねばに 
80°C. Whole populations were also plated out on non-selective media, 20 ねばぬ 
individual clones were then randomly selected, sub-cultured for a further 24 ねばね 
hours in non-selective media, and stored in 25% glycerol in 96 well plates. ねばの 
 ねばは 
Relative Fitness  ねばば 
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The relative fitness of the evolved plasmid bearing versus ancestral plasmid ねばぱ 
free strain was estimated by direct competition, with six replicate strains per-ねばひ 
treatment. The competitions were initiated with 50 ȝl of 1:1 mixtures of ねぱど 
plasmid-bearing evolved strain and plasmid-bearing ancestral strain marked ねぱな 
with mCherry from overnight cultures in 5ml of non-selective NB media. The ねぱに 
relative fitness of the evolved strains was calculated by gaining exact viable ねぱぬ 
cell counts at 0 hours and 24 hours, strains were distinguished through ねぱね 
detection of fluorescent markers using Zeis Stereo Lumar v12 microscope. ねぱの 
The relative fitness of plasmid-bearing bacteria was calculated as a ratio of ねぱは 
Malthusian parameters38:  ねぱば 
激勅塚墜 噺 ln 磐軽捗沈津銚鎮┸勅塚墜軽沈津沈痛銚鎮┸勅塚墜卑ln 磐軽捗沈津銚鎮┸銚津頂軽沈津沈痛銚鎮┸銚津頂卑 
 ねぱぱ 
Fitness effects due to different markers was determined by competing plasmid ねぱひ 
free MG1655-GFP with plasmid free MG1655-mCherry, the relative fitness of ねひど 
MG1655-GFP was not significantly difference from 1 (t5=0.015584, p=0.9882) ねひな 
showing that there is no significant difference between the two marker strains. ねひに 
 ねひぬ 
Relative fitness of evolved strains harbouring evolved plasmid or evolved ねひね 
strains harbouring ancestral plasmid versus ancestral plasmid bearing cells ねひの 
was estimated using the same method as above, with eighteen replicate ねひは 
strains per competition, but grown in 100 ȝl cultures in a 96 well plate, 37°C ねひば 
shaken at 600 rpm, 3 mm orbital radius, inoculated to an initial dilution of ねひぱ 
1:500. Again no fitness effect of markers was observed (t5=-0.2795, p=0.791). ねひひ 
 のどど 
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Curing RK2 from evolved strains のどな 
Evolved strains were cured using the pCURE curing system30. The anti-incP-1 のどに 
cassette (RK2 oriV, parD, korA, and incC genes) from pCURE11 was ligated のどぬ 
into the pLAZ2 chloramphenicol resistant vector that contains the sacB gene のどね 
allowing counter selection for plasmid free segregants. The resultant plasmid のどの 
was transformed into chemically competent evolved strains and selected for のどは 
using Cml 12.5 ȝg/ml. Single colony transformants were re-streaked on to のどば 
Cml 12.5 ȝg/ml plates and Cml 12.5 ȝg/ml + 5% sucrose. Sucrose sensitive のどぱ 
colonies were checked by PCR for the presence of the curing plasmid (Fw: のどひ 
aagttttggtgactgcgctc, Rv: caaagacgatgtggtagccg) and absence of RK2 ȕ-のなど 
lactamase and tetA (primers as above). Successfully cured clones were のなな 
cultured for 24 hours in non-selective media to allow segregation of the curing のなに 
plasmid; sergeants were selected on antibiotic free, 5% sucrose plates. To のなぬ 
confirm loss of both plasmids sucrose resistant colonies were check for のなね 
sensitivity to chloramphenicol, ampicillin, and tetracycline, as well as PCR のなの 
using primers mentioned above. Both the ancestral strain harbouring RK2 and のなは 
ancestral plasmid free strains under went the curing process and were used のなば 
as a comparison to cured evolved strains to control for curing process. のなぱ 
Ancestral RK2 was introduced into the cured evolved strains, and evolved のなひ 
RK2 was introduced into the plasmid free ancestor though conjugation. Again, のにど 
to control for the curing and conjugation steps, ancestral RK2 was conjugated のにな 
into cured ancestral strains and used for comparison. Saturated overnight のにに 
cultures of donor plasmid containing strains and recipient plasmid free strains のにぬ 
were mixed 1:1, and 50 ȝl was used to inoculate 5ml NB. The mixed cultures のにね 
were grown for 24 hours and plated out on to 100 ȝg/ml ampicillin to select for のにの 
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transconjugants. Transconjugants were confirmed by fluoresces and PCR のには 
screening for RK2 plasmid.  のにば 
 のにぱ 
MIC のにひ 
To measure minimal inhibitory concentrations, six replicate cultures per-のぬど 
treatment were grown overnight until stationary phase in 5 ml NB, the のぬな 
saturated cultures were then sub-cultured 50 ȝl into 5 ml fresh NB and grown のぬに 
to an OD600 of 0.5. These were then diluted into 96-well plates containing a のぬぬ 
log2 serial dilution of antibiotic (AMP, TET or CML) to an initial density of のぬね 
5×105 CFU/ml. 100 ȝl cultures were grown for 24 hours 37°C shaken at 600 のぬの 
rpm, 3 mm orbital radius. OD600 was measured after 24 hours. のぬは 
 のぬば 
Growth Curves のぬぱ 
Six replicate saturated overnight cultures per-treatment were sub-cultured to のぬひ 
an OD600 of 0.5, and used to inoculate 100 ȝl NB supplemented with 10 ȝg/ml のねど 
TET per well in 96-well plates at a final dilution of 1:1000. Plates were grown のねな 
at 37°C with shaking at 300 rpm, 3 mm orbital radius for 24 hours, OD600 was のねに 
measured every 16 minutes by Tecan infinite M200 Pro plate reader. Growth のねぬ 
rates were calculated as the maximum slope of log2 transformed OD600 のねね 
covering four time points (~1 hour of growth), lag phase was calculated to end のねの 
when growth rate reached 10% of the maximum achieved growth rate. のねは 
 のねば 
Genome sequencing and analysis のねぱ 
Whole genomes were extracted from each evolved population’s clone as well のねひ 
as the ancestral strain and ancestral strain harbouring the RK2 plasmid using ののど 
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the DNeasy Blood and Tissue extraction kit (Qiagen). The total DNA was ののな 
sequenced by MicrobesNG (http://www.microbesng.uk), which is supported ののに 
by the BBSRC (grant number BB/L024209/1), using Illumnia MiSeq. Reads ののぬ 
were mapped to E. coli MG1655 K-12 genome (GenBank accession ののね 
U00096.3) and RK2 (GenBank accession BN000925.1) reference using BWA-ののの 
MEM39. Single nucleotide variants and small indel events were detected using ののは 
GATK UnifiedGenotyper40 and SnpEff41, insertion sequences were identified ののば 
using custom scripts and Integrative Genomics Viewer42, and large genome-ののぱ 
wide structural variants were detected using BreakDancer43. Mutations that ののひ 
were present in the ancestral clones were excluded, resulting in a set of のはど 
mutations that were acquired during the selection experiment. のはな 
 のはに 
Tracking mutations のはぬ 
Populations that did not show a hypermutator phenotype, had insertion のはね 
sequences within ompF, and mutations in the tetracycline resistance genes のはの 
on the plasmid, from the constant TET treatments (T and AT treatments) were のはは 
selected for further analysis to gain an understanding of the mutational のはば 
timeline during the selection experiment. Insertion sequences within ompF のはぱ 
were identified within whole populations of T4, AT2, AT3 and AT5 by PCR of のはひ 
the ompF gene (Fw: ACTTCAGACCAGTAGCCCAC, Rv: のばど 
GCGCAATATTCTGGCAGTGA). A short product of 716 bp indicated no のばな 
insertion sequence, a long product of 1484 bp indicted IS1 and a long product のばに 
of 1911 bp indicted IS5. Whole population PCR indicated that ompF::IS のばぬ 
mutants had swept into the population by transfer 40 for populations T4, AT2 のばね 
and AT5, and transfer 48 in population AT3. Frequency of ompF insertion のばの 
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sequences were calculated by PCR of 20 clones from transfers 8, 16, 24, 32, のばは 
and 40. Tetracycline resistance genes (tetA and tetR) from clones containing のばば 
ompF::IS mutations from population AT2, transfers 8, 16, 24, and 32 were のばぱ 
then Sanger sequenced to determine if ompF mutations arise before tetAR のばひ 
mutations (tetA: Fw: GGCTGCAACTTTGTCATG,Rv: のぱど 
TTCCAACCGCACTCCTAG, Internal1: ACAGCGCCTTTCCTTTG, Interal2: のぱな 
AAGGCAAGCAGGATGTAG; tetR: Fw: TCTGACGCGGTGGAAAG, Rv: のぱに 
ACGCGCGGATTCTTTATC, Internal1: GAGCCTGTTCAACGGTG, Internal2: のぱぬ 
TCTGACGACACGCAAAC). のぱね 
 のぱの 
Statistical analysis のぱは 
To test if the mutations observed within each treatment had significantly のぱば 
different variances a multivariate homogeneity of groups variances test was のぱぱ 
conducted44. The binary presence or absence of a variant at each allele was のぱひ 
use to calculate a Euclidean distance matrix between each population. This のひど 
was used to test for homogeneity of variances between treatments using のひな 
betadisper {vegan 2.4-0}. The variances between treatments were のひに 
significantly different, with hypermutators significantly affecting within-group のひぬ 
variation. These clones were removed from further analysis as significant のひね 
differences in within-group variance can lead to falsely significant results のひの 
when testing for differences between groups45. Permutational Multivariate のひは 
Analysis of Variance was used to calculate whether different evolutionary のひば 
treatments resulted in different sets of mutations45,46. Using the Euclidean のひぱ 
distance matrix with hypermutators removed, the significance of within- and のひひ 
between-group distances was calculated using adonis2 {vegan 2.4-0}. The はどど 
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data was partitioned into different groups, multiple testing was corrected for はどな 
using Bonferroni correction. Neighbour Joining phylogeny was constructed はどに 
using the binary presence or absence table with hypermutators removed. はどぬ 
Tree estimation and bootstrap support was conducted using ape-package はどね 
{ape 4.0}. Significant difference between two related samples was calculated はどの 
using two sided, two-sample t-test. Shapiro-Wilk test was conducted to check はどは 
for normality, when normality could not be assumed a non-parametric はどば 
Wilcoxon signed-rank test was used. Differences among treatments growth はどぱ 
under antibiotic selection were calculated by ANOVA of the integral of the はどひ 
resistance profiles, with subsequent Tukey multiple comparison of means. All はなど 
statistical analysis was conducted in R (version 3.2.3). はなな 
 はなに 
Data Availability はなぬ 
The sequence data supporting the findings of this study are available at the はなね 
European Nucleotide Archive, accession: PRJEB20735. All other data in this はなの 
study is available at Figshare data depository はなは 
(https://doi.org/10.6084/m9.figshare.5092225.v1). Custom code used to map はなば 
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 はねど 
Figure 1 | Resistance profiles of evolved plasmids and hosts. Growth of はねな 
a, evolved MG1655 strains with evolved RK2 plasmids b, evolved MG1655 はねに 
strains cured of evolved RK2 plasmids c, evolved MG1655 strains with はねぬ 
ancestral RK2 plasmid and d, ancestral MG1655 clones with evolved RK2 はねね 
plasmids in the presence of tetracycline, ampicillin or chloramphenicol in はねの 
comparison to ancestral MG1655. Points represent means of one clone from はねは 
each of the six independent treatment populations, with SEM error bars. はねば 
Dashed grey and black lines show the resistance profiles of plasmid free and はねぱ 
plasmid containing ancestral strains respectively. Dashed lines in evolved はねひ 
host cured of plasmid plots (c) show ancestral MG1655 and ancestral はのど 
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MG1655(RK2) after curing process. Dashed lines in ancestral host evolved はのな 
plasmid plots (d) show ancestral MG1655 and ancestral MG1655(RK2) which はのに 
had under gone curing with ancestral RK2 subsequently reintroduced.  はのぬ 
Vertical dashed lines in AMP and TET resistance profiles show the はのね 
concentrations of AMP (100 ȝg/ml) or TET (10 ȝg/ml) used in the selection はのの 
experiment. はのは 
 はのば 
Figure 2 | Mutations show treatment specific parallelism. a, An unrooted はのぱ 
neighbour joining phylogeny of end-point evolved clones. The distance matrix はのひ 
was constructed from the binary presence or absence of variants at each ははど 
gene relative to the ancestral strain; hypermutators were excluded from the ははな 
analysis. Scale bar represents number of gene variants; percentage bootstrap ははに 
support is shown at the branches, B=1000, values below 0.3 are omitted. Blue ははぬ 
branches represent clone isolated from TET treatments. b, Mutations ははね 
observed in evolved clones (excluding hypermutators) across treatment. ははの 
Rings represent E. coli chromosomes or RK2 plasmids. Dots represent ははは 
mutations, the size of the dots represent the number of mutations at the same ははば 
loci across independent replicate populations. Plots of individual treatments ははぱ 
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